Idarucizumab and factor Xa reversal agents: role in hospital guidelines and protocols

Author(s):: Huisman, M.V. (0000-0003-1423-5348); Fanikos, J.

Published: 2016
Publication type: Article / Letter to editor

Date issued: 2016-11-30
Language: English
Is part of: The American Journal of Emergency Medicine (2016), Vol. 34, no. 11, p. 46-51
hdl: 1887/74114
doi: 10.1016/j.ajem.2016.09.053
URL: https://www.sciencedirect.com/science/article/pii/S0002934316306660